A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

Por Sundar, Raghav, Rha, Sun Young, Yamaue, Hiroki, Katsuda, Masahiro, Kono, Koji, Kim, Hyo Song, Kim, Chan, Mimura, Kousaku, Kua, Ley-Fang, Yong, Wei Peng
Publicado no BMC Cancer (2018)

Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non–small-cell lung cancer

Por Bondarenko, Igor M, Ingrosso, Antonella, Bycott, Paul, Kim, Sinil, Cebotaru, Cristina L
Publicado no BMC Cancer (2015)

A phase II trial of the nucleolin-targeted DNA aptamer AS1411 in metastatic refractory renal cell carcinoma

Por Rosenberg, Jonathan E., Bambury, Richard, Drabkin, Harry A., Lara, Primo N., Harzstark, Andrea L., Figlin, Robert A., Smith, Gregory W., Choueiri, Toni, Erlandsson, Fredrik, Laber, Damian A.
Publicado no Invest New Drugs (2013)

Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer

Por Park, In Hae, Kong, Sun-Young, Kwon, Youngmee, Kim, Min Kyeong, Sim, Sung Hoon, Joo, Jungnam, Lee, Keun Seok
Publicado no J Cancer (2018)

Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria

Por Halpern, Vera, Ogunsola, Folasade, Obunge, Orikomaba, Wang, Chin-Hua, Onyejepu, Nneka, Oduyebo, Oyinola, Taylor, Doug, McNeil, Linda, Mehta, Neha, Umo-Otong, John, Otusanya, Sakiru, Crucitti, Tania, Abdellati, Said
Publicado em 2008

A Phase II Multi‐Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma

Por Burotto, Mauricio, Edgerly, Maureen, Velarde, Margarita, Balasubramaniam, Sanjeeve, Drabkin, Harry, Gormaz, Juan G., O'Sullivan, Ciara, Madan, Ravi, Fojo, Tito
Publicado no Oncologist (2017)

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

Por Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Publicado em 2013

Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study

Por Ohtsu, Atsushi, Ajani, Jaffer A., Bai, Yu-Xian, Bang, Yung-Jue, Chung, Hyun-Cheol, Pan, Hong-Ming, Sahmoud, Tarek, Shen, Lin, Yeh, Kun-Huei, Chin, Keisho, Muro, Kei, Kim, Yeul Hong, Ferry, David, Tebbutt, Niall C., Al-Batran, Salah-Eddin, Smith, Heind, Costantini, Chiara, Rizvi, Syed, Lebwohl, David, Van Cutsem, Eric
Publicado no J Clin Oncol (2013)

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Por Zelenetz, Andrew D., Salles, Gilles, Mason, Kylie D., Casulo, Carla, Le Gouill, Steven, Sehn, Laurie H., Tilly, Herve, Cartron, Guillaume, Chamuleau, Martine E. D., Goy, Andre, Tam, Constantine S., Lugtenburg, Pieternella J., Petrich, Adam M., Sinha, Arijit, Samineni, Divya, Herter, Sylvia, Ingalla, Ellen, Szafer-Glusman, Edith, Klein, Christian, Sampath, Deepak, Kornacker, Martin, Mobasher, Mehrdad, Morschhauser, Franck
Publicado no Blood (2019)

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

Por Mori, Etsuro, Ikeda, Manabu, Nagai, Reiko, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Publicado no Alzheimers Res Ther (2015)

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

Por Kumada, Hiromitsu, Suzuki, Yoshiyuki, Karino, Yoshiyasu, Chayama, Kazuaki, Kawada, Norifumi, Okanoue, Takeshi, Itoh, Yoshito, Mochida, Satoshi, Toyoda, Hidenori, Yoshiji, Hitoshi, Takaki, Shintaro, Yatsuzuka, Naoyoshi, Yodoya, Etsuo, Iwasa, Takashi, Fujimoto, Go, Robertson, Michael N., Black, Stuart, Caro, Luzelena, Wahl, Janice
Publicado no J Gastroenterol (2016)

Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Por Lindemann, Kristina, Malander, Susanne, Christensen, Rene D, Mirza, Mansoor R, Kristensen, Gunnar B, Aavall-Lundqvist, Elisabeth, Vergote, Ignace, Rosenberg, Per, Boman, Karin, Nordstrøm, Britta
Publicado em 2014

Phase II Trial Of Neoadjuvant Axitinib In Patients With Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma

Por Karam, Jose A., Devine, Catherine E., Urbauer, Diana L., Lozano, Marisa, Maity, Tapati, Ahrar, Kamran, Tamboli, Pheroze, Tannir, Nizar M., Wood, Christopher G.
Publicado no Eur Urol (2014)

Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10–17)

Por Choi, Y J, Lee, S H, Lee, J-L, Ahn, J-H, Lee, K-H, You, D, Hong, B, Hong, J H, Ahn, H
Publicado no Br J Cancer (2015)

ACTR-19. A MULTICENTER PILOT PHASE II STUDY OF CONTINUING TMZ WITH THE ADDITION OF DISULFIRAM AND COPPER FOR REFRACTORY GLIOBLASTOMA

Por Huang, Jiayi, Chaudhary, Rehka, Cohen, Adam, Fink, Karen, Godlust, Samuel, Boockvar, John, Chinnaiyan, Prakash, Marcus, Stephen, Campian, Jian
Publicado no Neuro Oncol (2018)

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma(†)

Por Kunwar, Sandeep, Chang, Susan, Westphal, Manfred, Vogelbaum, Michael, Sampson, John, Barnett, Gene, Shaffrey, Mark, Ram, Zvi, Piepmeier, Joseph, Prados, Michael, Croteau, David, Pedain, Christoph, Leland, Pamela, Husain, Syed R., Joshi, Bharat H., Puri, Raj K.
Publicado em 2010

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

Por Riechelmann, Rachel P., Leite, Luiz S., Bariani, Giovanni M., Glasberg, Joao, Rivelli, Thomas G., da Fonseca, Leonardo Gomes, Nebuloni, Daniela R., Braghiroli, Maria I., Queiroz, Marcelo A., Isejima, Alice M., Kappeler, Christian, Kikuchi, Luciana, Hoff, Paulo M.
Publicado no Oncologist (2019)

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

Por Mouriaux, F, Servois, V, Parienti, J J, Lesimple, T, Thyss, A, Dutriaux, C, Neidhart-Berard, E M, Penel, N, Delcambre, C, Peyro Saint Paul, L, Pham, A D, Heutte, N, Piperno-Neumann, S, Joly, F
Publicado no Br J Cancer (2016)

Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial

Por Briez, Nicolas, Piessen, Guillaume, Bonnetain, Franck, Brigand, Cécile, Carrere, Nicolas, Collet, Denis, Doddoli, Christophe, Flamein, Renaud, Mabrut, Jean-Yves, Meunier, Bernard, Msika, Simon, Perniceni, Thierry, Peschaud, Frédérique, Prudhomme, Michel, Triboulet, Jean-Pierre, Mariette, Christophe
Publicado em 2011

Autologous Stem Cells in Achilles Tendinopathy (ASCAT): protocol for a phase IIA, single-centre, proof-of-concept study

Por Goldberg, Andrew J, Zaidi, Razi, Brooking, Deirdre, Kim, Louise, Korda, Michelle, Masci, Lorenzo, Green, Ruth, O’Donnell, Paul, Smith, Roger
Publicado no BMJ Open (2018)